The fifth Advances in Malignant Lymphoma: From Discovery to Clinical Impact conference brings together experts from academia, industry, government, and research foundations to discuss how molecular biology, translational research, and emerging therapies are advancing the understanding and treatment of lymphoma. The meeting focuses on bridging basic science discoveries with clinical applications to improve patient outcomes.